Inhaled nitric oxide for reducing major adverse events requiring intensive life support in adults undergoing cardiac surgery with cardiopulmonary bypass: protocol for a phase III, double-blind, multicenter randomized controlled trial (NORISC Trial).

Wang L, Kamenshchikov NO, Zhang H, Huang M, Tyo MA, Кoyanidi AY, Shi J, Evgeny G, Sergey P, Zhang Z, Yang X, Gao B, Boboshko V, Moroz G, Vasilev M, Zhai W, Min J, Liu Z, Wang J, Miao ZH, Wu Q, Song Z, Berra L, Lei C

Open source

DOI
10.1016/j.niox.2026.06.005
Published
2026 Oct
Container
Nitric oxide : biology and chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.niox.2026.06.005,
  title = {Inhaled nitric oxide for reducing major adverse events requiring intensive life support in adults undergoing cardiac surgery with cardiopulmonary bypass: protocol for a phase III, double-blind, multicenter randomized controlled trial (NORISC Trial).},
  author = {Wang L and Kamenshchikov NO and Zhang H and Huang M and Tyo MA and Кoyanidi AY and Shi J and Evgeny G and Sergey P and Zhang Z and Yang X and Gao B and Boboshko V and Moroz G and Vasilev M and Zhai W and Min J and Liu Z and Wang J and Miao ZH and Wu Q and Song Z and Berra L and Lei C},
  year = {2026},
  journal = {Nitric oxide : biology and chemistry},
  doi = {10.1016/j.niox.2026.06.005},
  url = {https://doi.org/10.1016/j.niox.2026.06.005}
}

RIS

TY  - JOUR
TI  - Inhaled nitric oxide for reducing major adverse events requiring intensive life support in adults undergoing cardiac surgery with cardiopulmonary bypass: protocol for a phase III, double-blind, multicenter randomized controlled trial (NORISC Trial).
AU  - Wang L
AU  - Kamenshchikov NO
AU  - Zhang H
AU  - Huang M
AU  - Tyo MA
AU  - Кoyanidi AY
AU  - Shi J
AU  - Evgeny G
AU  - Sergey P
AU  - Zhang Z
AU  - Yang X
AU  - Gao B
AU  - Boboshko V
AU  - Moroz G
AU  - Vasilev M
AU  - Zhai W
AU  - Min J
AU  - Liu Z
AU  - Wang J
AU  - Miao ZH
AU  - Wu Q
AU  - Song Z
AU  - Berra L
AU  - Lei C
PY  - 2026
JO  - Nitric oxide : biology and chemistry
DO  - 10.1016/j.niox.2026.06.005
UR  - https://doi.org/10.1016/j.niox.2026.06.005
ER  - 

APA

L, W., NO, K., H, Z., M, H., MA, T., AY, К., J, S., G, E., P, S., Z, Z., X, Y., B, G., V, B., G, M., M, V., W, Z., J, M., Z, L., J, W., ZH, M., Q, W., Z, S., L, B., & C, L. (2026). Inhaled nitric oxide for reducing major adverse events requiring intensive life support in adults undergoing cardiac surgery with cardiopulmonary bypass: protocol for a phase III, double-blind, multicenter randomized controlled trial (NORISC Trial).. Nitric oxide : biology and chemistry. https://doi.org/10.1016/j.niox.2026.06.005

Source records